Eupraxia Pharmaceuticals (EPRXF) News Today C$2.99 -0.01 (-0.33%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Eupraxia Pharmaceuticals Hosts Webinar on Digestive DisordersNovember 13, 2024 | markets.businessinsider.comEupraxia Pharmaceuticals Reports Q3 Progress and FundingNovember 9, 2024 | markets.businessinsider.comEupraxia Pharmaceuticals Secures C$44.5 Million InvestmentOctober 31, 2024 | markets.businessinsider.comHealth Rounds: Steroid injection relieves knee arthritis pain for monthsOctober 16, 2024 | reuters.comClosing Bell: Eupraxia Pharmaceuticals Inc down on Tuesday (EPRX)August 19, 2024 | theglobeandmail.comClosing Bell: Eupraxia Pharmaceuticals Inc down on Monday (EPRX)May 29, 2024 | theglobeandmail.comEupraxia Pharmaceuticals expands trial of eosinophilic esophagitis therapyMay 24, 2024 | msn.comEupraxia Pharmaceuticals Shares Pop After New Trial DataMay 21, 2024 | marketwatch.comEupraxia Pharmaceuticals Inc Ordinary SharesMay 18, 2024 | morningstar.comEQS-News: CHEPLAPHARM closes financial year 2023 with record revenue and double-digit growthApril 27, 2024 | markets.businessinsider.comEupraxia Pharmaceuticals Inc (EPRX-WT.TO)April 20, 2024 | ca.finance.yahoo.comEupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024April 11, 2024 | finance.yahoo.comEupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024April 11, 2024 | prnewswire.comEupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024April 3, 2024 | finance.yahoo.comEupraxia Pharmaceuticals Reports Fourth Quarter and 2023 Financial ResultsApril 1, 2024 | finance.yahoo.comEQS-News: APONTIS PHARMA expects profitable growth again in 2024March 29, 2024 | markets.businessinsider.comEupraxia Pharmaceuticals Announces Closing of Overnight Marketed Offering for Gross Proceeds of C$33.9 MillionMarch 15, 2024 | finance.yahoo.comEupraxia Pharma Shares Drop After Stock Offering PricesMarch 12, 2024 | marketwatch.comCanadian Investment Regulatory Organization Trade Resumption - EPRXMarch 12, 2024 | finance.yahoo.comEupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering of $30 MillionMarch 12, 2024 | finance.yahoo.comEupraxia Pharmaceuticals Announces Overnight Marketed Offering of Approximately $30 MillionMarch 11, 2024 | finance.yahoo.comProfit Setback For Simcere Pharma In Novel Drugs QuestMarch 1, 2024 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Morphic Holding (MORF) and Vertex Pharmaceuticals (VRTX)February 27, 2024 | markets.businessinsider.comWest Pharmaceutical reports mixed Q4 results; initiates FY24 outlookFebruary 15, 2024 | msn.comMedical equipment maker West Pharmaceutical forecasts weak annual resultsFebruary 15, 2024 | reuters.comVertex Pharmaceuticals 4Q Net, Revenue Beat EstimatesFebruary 6, 2024 | marketwatch.comEupraxia Pharmaceuticals Announces Updated Positive Clinical Data in EP-104GI RESOLVE Trial for the Treatment of Eosinophilic EsophagitisFebruary 5, 2024 | finance.yahoo.comEupraxia Pharmaceuticals Initiates Phase 3 Development Program for EP-104IARFebruary 1, 2024 | finance.yahoo.comEupraxia Pharmaceuticals Announces Positive Data from MRI Exploratory Sub-Study in Phase 2 SPRINGBOARD Trial Evaluating the Safety and Efficacy of EP-104IAR for the Treatment of Osteoarthritis of the KneeJanuary 30, 2024 | finance.yahoo.comEupraxia Pharmaceuticals Announces Filing of Preliminary MJDS Base Shelf ProspectusJanuary 8, 2024 | finance.yahoo.comLexicon Pharmaceuticals: Navigating The Competitive HFpEF Landscape (Rating Downgrade)January 1, 2024 | seekingalpha.comEupraxia Pharmaceuticals Inc Ordinary Shares EPRXDecember 16, 2023 | morningstar.comEditas Medicine Strikes License Deal With Vertex Pharmaceuticals -- UpdateDecember 13, 2023 | marketwatch.comStocks in play: Eupraxia Pharmaceuticals Inc.December 12, 2023 | ca.finance.yahoo.comEupraxia Pharmaceuticals Announces Positive Clinical Data in EP-104GI RESOLVE TrialDecember 12, 2023 | finance.yahoo.comEupraxia Pharmaceuticals Announces Clinical and Corporate UpdateDecember 11, 2023 | finance.yahoo.comVerrica Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 | markets.businessinsider.comMirum Pharmaceuticals earnings preview: what Wall Street is expectingNovember 1, 2023 | markets.businessinsider.comEupraxia Pharmaceuticals to Present at the 2023 Annual Meeting of the American College of RheumatologyNovember 1, 2023 | finance.yahoo.comDechra Pharmaceuticals rises Friday, outperforms marketOctober 27, 2023 | marketwatch.comWest Pharma Cuts 2023 Sales View, Boosts Adjusted Earnings View, as Ordering Trends ChangeOctober 26, 2023 | marketwatch.comClosing Bell: Eupraxia Pharmaceuticals Inc WT down on Wednesday (EPRX-WT)October 12, 2023 | theglobeandmail.comClosing Bell: Eupraxia Pharmaceuticals Inc WT down on Tuesday (EPRX-WT)October 11, 2023 | theglobeandmail.comEupraxia Pharmaceuticals Announces Initiation of Second Cohort in Phase 1b/2a Clinical Trial in Eosinophilic EsophagitisOctober 11, 2023 | finance.yahoo.comSyndax Pharma falls after early data for leukemia therapyOctober 2, 2023 | seekingalpha.comClosing Bell: Eupraxia Pharmaceuticals Inc down on Friday (EPRX)September 29, 2023 | theglobeandmail.comJefferies upgrades this pharma stock, citing overlooked 'blockbuster' drug opportunitiesSeptember 25, 2023 | cnbc.comDechra Pharmaceuticals rises Wednesday, still underperforms marketSeptember 20, 2023 | marketwatch.comDirexion Daily Pharmaceutical & Medical Bull 3X Shares declares quarterly distribution of $0.0353September 20, 2023 | msn.comEupraxia Pharmaceuticals Announces Change of AuditorSeptember 7, 2023 | finance.yahoo.com Get Eupraxia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for EPRXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. EPRXF Media Mentions By Week EPRXF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EPRXF News Sentiment▼0.000.60▲Average Medical News Sentiment EPRXF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EPRXF Articles This Week▼00▲EPRXF Articles Average Week Get Eupraxia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for EPRXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Ascentage Pharma Group International News Ascletis Pharma News Avacta Group News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:EPRXF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EPRXF Stock Alerts